Cardiol Therapeutics Inc.
CRDL
$1.14
-$0.005-0.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.34M | 16.21M | 21.25M | 11.76M | 17.55M |
| Total Receivables | 205.20K | 241.20K | 251.30K | 197.40K | 177.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 952.60K | 1.14M | 504.90K | 836.40K | 1.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.50M | 17.58M | 22.01M | 12.79M | 18.91M |
|
|
|||||
| Total Current Assets | 14.50M | 17.58M | 22.01M | 12.79M | 18.91M |
| Net Property, Plant & Equipment | 119.90K | 127.00K | 135.90K | 176.10K | 192.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | 0.00 | 122.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.62M | 17.71M | 22.15M | 12.97M | 19.23M |
|
|
|||||
| Total Accounts Payable | 5.86M | 5.37M | 4.85M | 5.12M | 6.89M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.10K | 23.80K | 22.90K | 23.50K | 15.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 2.70K | 990.60K |
| Total Other Current Liabilities | -- | -- | -- | 2.70K | 990.60K |
| Total Current Liabilities | 5.88M | 5.39M | 4.87M | 5.15M | 7.90M |
|
|
|||||
| Total Current Liabilities | 5.88M | 5.39M | 4.87M | 5.15M | 7.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 78.50K | 81.00K | 87.20K | 99.30K | 104.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.96M | 5.47M | 4.96M | 5.25M | 8.00M |
|
|
|||||
| Common Stock & APIC | 152.29M | 142.71M | 141.77M | 134.82M | 126.92M |
| Retained Earnings | -143.63M | -130.48M | -124.58M | -127.10M | -115.70M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.66M | 12.24M | 17.19M | 7.72M | 11.22M |
|
|
|||||